首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Docking study: PPARs interaction with the selected alternative plasticizers to di(2-ethylhexyl) phthalate
【24h】

Docking study: PPARs interaction with the selected alternative plasticizers to di(2-ethylhexyl) phthalate

机译:对接研究:PPAR与选定的替代增塑剂与邻苯二甲酸二(2-乙基己基)酯的相互作用

获取原文
       

摘要

Abstract Phthalates, used in medical devices (MDs), have been identified as reproductive and developmental toxicants. Their toxicity varies somewhat depending on the specific phthalate and is in part linked to the activation of Peroxisome Proliferating-Activated Receptors (PPARs). So, the use of MDs containing targeted phthalates such as di(2-ethylhexyl) phthalate (DEHP) has been challenged by European directive 2007/47/EC. Therefore, MDs manufacturers were forced to quickly find replacement plasticizers. However, very little toxicological and epidemiological studies are available on human health. So, we proceeded to dock these chemicals in order to identify compounds that are likely to interact with PPARs binding sites. The results obtained are generally very mixed on the harmlessness of these alternatives. Moreover, no data exist on the biological effects of their possible metabolites. As DEHP toxicity resulted mainly from its major metabolites, generalizing the use of these plasticizers without conducting extensive studies on the possible effects on human health of their metabolites seems inconceivable.
机译:摘要用于医疗器械(MDs)的邻苯二甲酸酯已被确定为生殖和发育毒性物质。它们的毒性取决于特定的邻苯二甲酸酯而有所不同,并且部分与过氧化物酶体增殖激活受体(PPAR)的激活有关。因此,欧洲指令2007/47 / EC挑战了含有目标邻苯二甲酸酯(例如邻苯二甲酸二(2-乙基己基)酯(DEHP))的MD的使用。因此,MD制造商被迫迅速寻找替代增塑剂。但是,关于人体健康的毒理学和流行病学研究很少。因此,我们着手对接这些化学物质,以鉴定可能与PPAR结合位点相互作用的化合物。在这些替代方案的无害性方面,获得的结果通常非常复杂。而且,没有关于其可能代谢物的生物学效应的数据。由于DEHP的毒性主要是由其主要代谢产物引起的,因此无法对这些增塑剂的普遍使用进行广泛的研究,而无需对其代谢物对人体健康的可能影响进行广泛研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号